Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2026-02-22 @ 10:28 AM
Study NCT ID:
NCT00110006
Status:
WITHDRAWN
Last Update Posted:
2010-06-11
First Post:
2005-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Sponsor:
Case Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | contiguous stage II grade 3 follicular lymphoma | View |
| None | noncontiguous stage II grade 3 follicular lymphoma | View |
| None | stage I grade 3 follicular lymphoma | View |
| None | stage III grade 3 follicular lymphoma | View |
| None | stage IV grade 3 follicular lymphoma | View |
| None | contiguous stage II adult diffuse large cell lymphoma | View |
| None | noncontiguous stage II adult diffuse large cell lymphoma | View |
| None | stage I adult diffuse large cell lymphoma | View |
| None | stage III adult diffuse large cell lymphoma | View |
| None | stage IV adult diffuse large cell lymphoma | View |
| None | contiguous stage II mantle cell lymphoma | View |
| None | noncontiguous stage II mantle cell lymphoma | View |
| None | stage I mantle cell lymphoma | View |
| None | stage III mantle cell lymphoma | View |
| None | stage IV mantle cell lymphoma | View |
| None | anaplastic large cell lymphoma | View |